產(chǎn)品名稱:重組人bFGF蛋白
貨號:GMP-TL901
2023-12-25
GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
產(chǎn)品名稱: 重組人EGF蛋白
貨號:GMP-TL613
2023-12-25
GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
產(chǎn)品名稱:AMMS?MSC 試劑盒套裝2.0
貨號:AS-13
2023-11-03
Improved Cell Properties of Human Dental Pulp Stem Cells (hDPSCs) Isolated and Expanded in a GMP Compliant and Xenogeneic Serum-free Medium
產(chǎn)品名稱:重組人IL-7蛋白
貨號:GMP-TL506
2023-09-09
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
產(chǎn)品名稱:重組人IL-15蛋白
貨號:GMP-TL202
2023-09-09
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
產(chǎn)品名稱:重組人IL-21蛋白
貨號:GMP-TL509
2023-09-09
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
產(chǎn)品名稱:抗人CD3單克隆抗體
貨號:GMP-TL101
2023-09-09
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
產(chǎn)品名稱:抗人CD28單克隆抗體
貨號:GMP-TL102
2023-09-09
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
產(chǎn)品名稱:AMMS?NK試劑盒套裝
2023-05-22
Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape
產(chǎn)品名稱:重組人IFN-γ蛋白
貨號:GMP-TL105
2023-05-01
miR-1187 induces podocyte injury and diabetic nephropathy through autophagy